Plasmid vectors encoding cholera toxin or the heat-labile enterotoxin from Escherichia coli are strong adjuvants for DNA vaccines

Journal of Virology

Volumn 76, Issue 9, 2002, Pages 4536-4546

  Arrington, Joshua ^a   Braun, Ralph P ^a   Dong, Lichun ^a   Fuller, Deborah H ^a   Macklin, Michael D ^a   Umlauf, Scott W ^a   Wagner, Sarah J ^a   Wu, Mary S ^a   Payne, Lendon G ^a   Haynes, Joel R ^a  

^a PowderJect Vaccines Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; CHOLERA TOXIN; CYCLIC AMP; DNA VACCINE; ENTEROTOXIN; GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERLEUKIN 4; PLASMID VECTOR; PROTEIN SUBUNIT; SIGNAL PEPTIDE; VIRUS ANTIGEN;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; BACTERIAL GENE; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CONTROLLED STUDY; CPG ISLAND; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG SAFETY; EPIDERMIS; ESCHERICHIA COLI; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RODENT; SWINE; TH1 CELL;

ADJUVANTS, IMMUNOLOGIC; AIDS VACCINES; ANIMALS; ANTIBODIES, VIRAL; BACTERIAL TOXINS; CACO-2 CELLS; CHOLERA TOXIN; ENTEROTOXINS; ESCHERICHIA COLI PROTEINS; GENETIC VECTORS; HIV ENVELOPE PROTEIN GP120; HUMANS; IMMUNIZATION; INFLUENZA VACCINES; MICE; PLASMIDS; SWINE; T-LYMPHOCYTES; TRANSFECTION; VACCINES, DNA; VIRAL MATRIX PROTEINS;

EID: 0036231460     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.9.4536-4546.2002     Document Type: Article

References (51)

1. How do you see CG?
2. The influenza virus M2 ion channel protein: Probing the structure of the transmembrane domain in intact cells by using engineered disulfide cross-linking
3. Differential biological and adjuvant activities of cholera toxin and Escherichia coli heat-labile enterotoxin hybrids
4. Vaccination of seronegative volunteers with a human immunodeficiency virus type 1 env/rev DNA vaccine induces antigen-specific proliferation and lymphocyte production of beta-chemokines
5. Cholera toxin suppresses interleukin (IL)-12 production and IL-12 receptor betal and beta2 chain expression
6. Serum and mucosal immune responses to an inactivated influenza virus vaccine induced by epidermal powder immunization
7. The role of cAMP in mucosal adjuvanticity of Escherichia coli heat-labile enterotoxin (LT)
8. LT(R192G), a non-toxic mutant of the heat-labile enterotoxin of Escherichia coli, elicits enhanced humoral and cellular immune responses associated with protection against lethal oral challenge with Salmonella spp
9. Role of a potential endoplasmic reticulum retention sequence (RDEL) and the Golgi complex in the cytotonic activity of Escherichia coli heat-labile enterotoxin
10. Isolation and characterization of homogeneous heat-labile enterotoxins with high specific activity from Escherichia coli cultures
11. Properties of homogeneous heat-labile enterotoxin from Escherichia coli
12. DNA-based immunization by in vivo transfection of dendritic cells
13. Genetically derived toxoids for use as vaccines and adjuvants
14. DNA vaccines
15. Mucosal immunogenicity of genetically detoxified derivatives of heat labile toxin from Escherichia coli
16. The induction of systemic and mucosal immune responses to antigen-adjuvant compositions administered into the skin: Alterations in the migratory properties of dendritic cells appears to be important for stimulating mucosal immunity
17. Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization
18. Modified M2 proteins produce heterotypic immunity against influenza A virus
19. A qualitative progression in HIV type 1 glycoprotein 120-specific cytotoxic cellular and humoral immune responses in mice receiving a DNA-based glycoprotein 120 vaccine
20. Cholera toxin induces maturation of human dendritic cells and licences them for Th2 priming
21. Transcutaneous immunization with bacterial ADP-ribosylating exotoxins as antigens and adjuvants
22. Transcutaneous immunization: A human vaccine delivery strategy using a patch
23. Genetic vaccines
24. Engineering enhancement of immune responses to DNA-based vaccines in a prostate cancer model in rhesus macaques through the use of cytokine gene adjuvants
25. Direct transfection and activation of human cutaneous dendritic cells
26. Safety, tolerability and humoral immune responses after intramuscular administration of a malaria DNA vaccine to healthy adult volunteers
27. Targeting of cholera toxin and Escherichia coli heat labile toxin in polarized epithelia: Role of COOH-terminal KDEL
28. Transcytosis of cholera toxin subunits across model human intestinal epithelia
29. Immunization of pigs with a particle-mediated DNA vaccine to influenza A virus protects against challenge with homologous virus
30. Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4
31. Comparative analysis of the mucosal adjuvanticity of the type II heat-labile enterotoxins LT-IIa and LT-IIb
32. + T cells
33. A universal influenza A vaccine based on the extracellular domain of the M2 protein
34. Heat-labile enterotoxin of Escherichia coli and its site-directed mutant LTK63 enhance the proliferative and cytotoxic T-cell responses to intranasally co-immunized synthetic peptides
35. Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery
36. Manipulation of HIV-1 gp120-specific immune responses elicited via gene gun-based DNA immunization
37. Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins
38. Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine
39. In vivo expression and immunoadjuvancy of a mutant of heat-labile enterotoxin of Escherichia coli in vaccine and vector strains of Vibrio cholerae
40. Immunogenicity and protective efficacy of a Plasmodium yoelii Hsp60 DNA vaccine in BALB/c mice
41. Principles of transcutaneous immunization using cholera toxin as an adjuvant
42. Transcutaneous immunization with bacterial ADP-ribosylating exotoxins, subunits, and unrelated adjuvants
43. Processing of exogenous heat-aggregated (denatured) and particulate (native) hepatitis B surface antigen for class I-restricted epitope presentation
44. Naked DNA vaccines expressing the prM and E genes of Russian spring summer encephalitis virus and Central European encephalitis virus protect mice from homologous and heterologous challenge
45. MHC class I-restricted cytotoxic lymphocyte responses induced by enterotoxin-based mucosal adjuvants
46. Modulation of cellular responses by plasmid CD40L: CD40L plasmid vectors enhance antigen-specific helper T cell type 1 CD4+ T-cell-mediated protective immunity against herpes simplex virus type 2 in vivo
47. Effects of site-directed mutagenesis of Escherichia coli heat-labile enterotoxin on ADP-ribosyltransferase activity and interaction with ADP-ribosylation factors
48. An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes
49. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine
50. Immune modulation by the cholera-like enterotoxins: From adjuvant to therapeutic
51. Helper T cell subsets for immunoglobulin A responses: Oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues